UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 221

Sortiert nach

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA

European urology, 2021-03, Vol.79 (3), p.343-350

2021

Link zum Volltext

Verfügbarkeit prüfen

Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer

The Journal of urology, 2016-08, Vol.196 (2), p.382

2016

Link zum Volltext

Verfügbarkeit prüfen

Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography

European urology, 2022-08, Vol.82 (2), p.156-160

2022

Link zum Volltext

Verfügbarkeit prüfen

Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions

The Journal of nuclear medicine (1978), 2017-03, Vol.58 (3), p.445-450

2017

Link zum Volltext

Verfügbarkeit prüfen

Detection of circulating tumor cells in different stages of prostate cancer

Journal of cancer research and clinical oncology, 2013-05, Vol.139 (5), p.755-763

2013

Link zum Volltext

Verfügbarkeit prüfen

AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide

European urology, 2017-11, Vol.72 (5), p.828-834

2017

Link zum Volltext

Verfügbarkeit prüfen

Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T

The Journal of nuclear medicine (1978), 2023-11, Vol.64 (11), p.1765-1771

2023

Link zum Volltext

Verfügbarkeit prüfen

Transitions between Lamellar Orientations in Shear Flow

Macromolecules, 2018-06, Vol.51 (12), p.4642-4659

2018

Link zum Volltext

Verfügbarkeit prüfen

Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer

European journal of nuclear medicine and molecular imaging, 2023-08, Vol.50 (10), p.3137-3146

2023

Link zum Volltext

Verfügbarkeit prüfen

Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy

European urology, 2021-04, Vol.79 (4), p.537-544

2021

Link zum Volltext

Verfügbarkeit prüfen

Reply to Giancarlo Marra, Armando Stabile, Paolo Gontero, Francesco Montorsi, Alberto Briganti, and Giorgio Gandaglia’s Letter to the Editor re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup

European urology, 2022-05, Vol.81 (5), p.e117-e117

2022

Link zum Volltext

Verfügbarkeit prüfen

EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer

Cancers, 2023-10, Vol.15 (20), p.5008

2023

Link zum Volltext

Verfügbarkeit prüfen

Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support

World journal of urology, 2023-09, Vol.41 (9), p.2343-2350

2023

Link zum Volltext

Verfügbarkeit prüfen

Positive Predictive Value and Correct Detection Rate of 18 F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard

Journal of Nuclear Medicine, 2021-07, Vol.62 (7), p.968-974

2021

Link zum Volltext

Verfügbarkeit prüfen

Topography of Lymph Node Metastases in Prostate Cancer Patients Undergoing Radical Prostatectomy and Extended Lymphadenectomy: Results of a Combined Molecular and Histopathologic Mapping Study

European urology, 2014-08, Vol.66 (2), p.222-229

2014

Link zum Volltext

Verfügbarkeit prüfen

Early Prostate-Specific Antigen Changes and Clinical Outcome After 177 Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine, 2020-10, Vol.61 (10), p.1476-1483

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of non-metastatic castration resistant prostate cancer in 2020: What is the best?

Urologic oncology, 2020-04, Vol.38 (4), p.129-136

2020

Link zum Volltext

Verfügbarkeit prüfen

Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients

European journal of nuclear medicine and molecular imaging, 2014-04, Vol.41 (4), p.694-701

2014

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, Predictive Factors, and Prediction Nomograms for 68 Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy

European urology, 2018-05, Vol.73 (5), p.656-661

2018

Link zum Volltext

Verfügbarkeit prüfen

One-Stop-Shop Whole-Body 68 Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer

Journal of Nuclear Medicine, 2018-12, Vol.59 (12), p.1850-1856

2018

Link zum Volltext

Verfügbarkeit prüfen

Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy

Anticancer research, 2015-10, Vol.35 (10), p.5679-5685

2015

Link zum Volltext

Verfügbarkeit prüfen

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients

BMC cancer, 2015-06, Vol.15 (1), p.458-458, Article 458

2015

Link zum Volltext

Verfügbarkeit prüfen

Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT

European radiology, 2014-08, Vol.24 (8), p.1821-1826

2014

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 221

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(211)

Sprache

Englisch
(216)
Japanisch
(36)
Deutsch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA

Extended Versus Limited Lymph Node Dissection in Bladder Cancer Patients Undergoing Radical Cystectomy: Survival Results from a Prospective, Randomized Trial

Systemic Radioligand Therapy with (177)Lu Labeled Prostate Specific Membrane Antigen Ligand for Imaging and Therapy in Patients with Metastatic Castration Resistant Prostate Cancer

Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography

Radiation Dosimetry for 177Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: Absorbed Dose in Normal Organs and Tumor Lesions

Detection of circulating tumor cells in different stages of prostate cancer

AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide

Cohort Study of Oligorecurrent Prostate Cancer Patients: Oncological Outcomes of Patients Treated with Salvage Lymph Node Dissection via Prostate-specific Membrane Antigen–radioguided Surgery

Improved Quality of Life in Metastatic Castration-Resistant Prostate Cancer Patients Receiving Consecutive Cycles of 177Lu-PSMA I&T

Transitions between Lamellar Orientations in Shear Flow

Development and external validation of a multivariable [68Ga]Ga-PSMA-11 PET-based prediction model for lymph node involvement in men with intermediate or high-risk prostate cancer

Salvage Surgery in Patients with Local Recurrence After Radical Prostatectomy

EAU Biochemical Recurrence Risk Classification and PSA Kinetics Have No Value for Patient Selection in PSMA-Radioguided Surgery (PSMA-RGS) for Oligorecurrent Prostate Cancer

Safety and efficiency of repeat salvage lymph node dissection for recurrence of prostate cancer using PSMA-radioguided surgery (RGS) after prior salvage lymph node dissection with or without initial RGS support

Positive Predictive Value and Correct Detection Rate of 18 F-rhPSMA-7 PET in Biochemically Recurrent Prostate Cancer Validated by Composite Reference Standard

Topography of Lymph Node Metastases in Prostate Cancer Patients Undergoing Radical Prostatectomy and Extended Lymphadenectomy: Results of a Combined Molecular and Histopathologic Mapping Study

Early Prostate-Specific Antigen Changes and Clinical Outcome After 177 Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer

Treatment of non-metastatic castration resistant prostate cancer in 2020: What is the best?

Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients

Efficacy, Predictive Factors, and Prediction Nomograms for 68 Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy

One-Stop-Shop Whole-Body 68 Ga-PSMA-11 PET/MRI Compared with Clinical Nomograms for Preoperative T and N Staging of High-Risk Prostate Cancer

Detection of Circulating Tumor Cells in Locally Advanced High-risk Prostate Cancer During Neoadjuvant Chemotherapy and Radical Prostatectomy

Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients

Preoperative lymph node staging in patients with primary prostate cancer: comparison and correlation of quantitative imaging parameters in diffusion-weighted imaging and 11C-choline PET/CT

Aktive Filter

Suchergebnisse filtern